AU2002301031A1 - S-Oxide and S,S-Dioxide Tetrahydrothiopyran Phenyloxazolidinones - Google Patents

S-Oxide and S,S-Dioxide Tetrahydrothiopyran Phenyloxazolidinones

Info

Publication number
AU2002301031A1
AU2002301031A1 AU2002301031A AU2002301031A AU2002301031A1 AU 2002301031 A1 AU2002301031 A1 AU 2002301031A1 AU 2002301031 A AU2002301031 A AU 2002301031A AU 2002301031 A AU2002301031 A AU 2002301031A AU 2002301031 A1 AU2002301031 A1 AU 2002301031A1
Authority
AU
Australia
Prior art keywords
phenyloxazolidinones
oxide
tetrahydrothiopyran
dioxide
dioxide tetrahydrothiopyran
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002301031A
Other versions
AU2002301031B2 (en
Inventor
Michael R Barbachyn
Joseph P Martin
Toni-Jo Poel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co LLC
Original Assignee
Pharmacia and Upjohn Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1998/024526 external-priority patent/WO1999029688A1/en
Application filed by Pharmacia and Upjohn Co LLC filed Critical Pharmacia and Upjohn Co LLC
Publication of AU2002301031A1 publication Critical patent/AU2002301031A1/en
Application granted granted Critical
Publication of AU2002301031B2 publication Critical patent/AU2002301031B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002301031A 1997-12-05 2002-09-16 S-Oxide and S,S-Dioxide Tetrahydrothiopyran Phenyloxazolidinones Ceased AU2002301031B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US6783097P 1997-12-05 1997-12-05
US60/067830 1997-12-05
US8949898P 1998-06-16 1998-06-16
US60/089498 1998-06-16
US10018598P 1998-09-14 1998-09-14
US60/100185 1998-09-14
PCT/US1998/024526 WO1999029688A1 (en) 1997-12-05 1998-11-23 S-oxide and s,s-dioxide tetrahydrothiopyran phenyloxazolidinones

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU17968/99A Division AU752454B2 (en) 1997-12-05 1998-11-23 S-oxide and s,s-dioxide tetrahydrothiopyran phenyloxazolidinones

Publications (2)

Publication Number Publication Date
AU2002301031A1 true AU2002301031A1 (en) 2003-02-20
AU2002301031B2 AU2002301031B2 (en) 2005-08-25

Family

ID=27371238

Family Applications (2)

Application Number Title Priority Date Filing Date
AU17968/99A Ceased AU752454B2 (en) 1997-12-05 1998-11-23 S-oxide and s,s-dioxide tetrahydrothiopyran phenyloxazolidinones
AU2002301031A Ceased AU2002301031B2 (en) 1997-12-05 2002-09-16 S-Oxide and S,S-Dioxide Tetrahydrothiopyran Phenyloxazolidinones

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU17968/99A Ceased AU752454B2 (en) 1997-12-05 1998-11-23 S-oxide and s,s-dioxide tetrahydrothiopyran phenyloxazolidinones

Country Status (22)

Country Link
US (2) US6083967A (en)
EP (2) EP1254906A1 (en)
JP (1) JP2001525408A (en)
KR (1) KR20010032782A (en)
CN (2) CN1532535A (en)
AT (1) ATE231859T1 (en)
AU (2) AU752454B2 (en)
BR (1) BR9814897A (en)
CA (1) CA2309026A1 (en)
DE (1) DE69811117T2 (en)
DK (1) DK1036074T3 (en)
ES (1) ES2191985T3 (en)
HK (1) HK1032970A1 (en)
HU (1) HUP0100558A3 (en)
ID (1) ID21450A (en)
NO (1) NO316447B1 (en)
NZ (1) NZ504930A (en)
PL (1) PL340835A1 (en)
SI (1) SI1036074T1 (en)
SK (1) SK7692000A3 (en)
TW (2) TWI239331B (en)
WO (1) WO1999029688A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6511468B1 (en) * 1997-10-17 2003-01-28 Micro Therapeutics, Inc. Device and method for controlling injection of liquid embolic composition
JP2002517498A (en) 1998-06-05 2002-06-18 アストラゼネカ アクチボラグ Chemical compound
MY120189A (en) * 1999-11-04 2005-09-30 Upjohn Co Sultam and sultone derived oxazolidinones
DE19962924A1 (en) 1999-12-24 2001-07-05 Bayer Ag Substituted oxazolidinones and their use
DE10129725A1 (en) 2001-06-20 2003-01-02 Bayer Ag Combination therapy of substituted oxazolidinones
AR038536A1 (en) 2002-02-25 2005-01-19 Upjohn Co N-ARIL-2-OXAZOLIDINONA-5- CARBOXAMIDS AND ITS DERIVATIVES
US7141588B2 (en) 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
WO2004014897A1 (en) 2002-08-12 2004-02-19 Pharmacia & Upjohn Company Llc N-aryl-2-oxazolidinones and their derivatives
DE60309504T2 (en) 2002-11-21 2007-05-16 Pharmacia & Upjohn Co. Llc, Kalamazoo N- (4- (PIPERAZIN-1-YL) -PHENYL-2-OXAZOLIDINONE-5-CARBOXYANAMIDE DERIVATIVES AND RELATED COMPOUNDS AS ANTIBACTERIAL AGENTS
DE10300111A1 (en) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Process for the preparation of 5-chloro-N - ({(5S) -2-oxo-3- [4- (3-oxo-4-morpholinyl) phenyl] -1,3-oxazolidin-5-yl} methyl ) -2-thiophenecarboxamide
US7304050B2 (en) 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
DE10355461A1 (en) 2003-11-27 2005-06-23 Bayer Healthcare Ag Solid, high bioavailabilty oral formulations of N-substituted 5-chloro-2-thiophene-carboxamide derivative in hydrophilized form, useful for combating thrombo-embolic diseases
DE102004062475A1 (en) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Solid, orally administrable, modified release pharmaceutical dosage forms
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005045518A1 (en) 2005-09-23 2007-03-29 Bayer Healthcare Ag New 5-thienylaminocarbonylmethyl-oxazolidin-2-one derivatives, useful for treating and preventing thromboembolic disease, are selective inhibitors of coagulation factor Xa
BRPI0616801B8 (en) 2005-10-04 2021-05-25 Bayer Healthcare Ag "polymorphic form of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl )-2-thiophenecarboxamide, its preparation processes and its uses, medicine, and process for preventing blood clotting in vitro
DE102005047558A1 (en) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Combination therapy of substituted oxazolidinones for the prophylaxis and treatment of cerebral circulatory disorders
DE102005047561A1 (en) 2005-10-04 2007-04-05 Bayer Healthcare Ag Drug delivery system, useful to treat and/or prevent e.g. thromboembolic disease, comprises 5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxo-4-morpholinyl)-phenyl)-1,3-oxazolidine-5-yl)-methyl)-2-thiophene carboxamide with fast release active substance
CN102262066A (en) * 2011-06-16 2011-11-30 董理 Method and kit for detecting monoamine oxidase content
CN104610479B (en) * 2013-11-05 2017-03-29 中国石油化工股份有限公司 Supported metallocene catalyst for vinyl polymerization and its preparation method and application

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1302422C (en) * 1986-09-03 1992-06-02 Margherita Strolin-Benedetti 5-aminoethyloxazolidin-2-one derivatives, process for the preparation thereofand their therapeutic use
US4885154A (en) * 1988-03-01 1989-12-05 Alza Corporation Method for reducing sensitization or irritation in transdermal drug delivery and means therefor
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
US5130316A (en) * 1988-07-29 1992-07-14 Du Pont Merck Pharmaceutical Company Aminomethyloxooxazlidinyl arylbenzene derivatives useful as antibacterial agents
US5254577A (en) * 1988-07-29 1993-10-19 The Du Pont Merck Pharmaceutical Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
JP2669579B2 (en) * 1991-10-23 1997-10-29 エーザイ株式会社 Oxazolidone derivatives
KR100257418B1 (en) * 1991-11-01 2000-05-15 로렌스 티. 마이젠헬더 Substituted aryl-and heteroaryl-phenyloxazolidinone
CZ288788B6 (en) * 1992-12-08 2001-09-12 Pharmacia & Upjohn Company Antibacterial phenyloxazolidinones substituted with tropone
US5968962A (en) * 1995-09-01 1999-10-19 Pharmacia & Upjohn Company Phenyloxazolidinones having a C-C bond to 4-8 membered heterocyclic rings
GB9702213D0 (en) * 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds

Similar Documents

Publication Publication Date Title
AU2002301031A1 (en) S-Oxide and S,S-Dioxide Tetrahydrothiopyran Phenyloxazolidinones
AU6705798A (en) Improved labeler
AU5491198A (en) Container
AU6075098A (en) Container
AU5566598A (en) Hydrogels
AU1962599A (en) Thienopyrimidines
AU7273398A (en) Wiper insert
AU1527499A (en) Pen
AU8979698A (en) Solutions containing azasteroids
AU9367198A (en) Enzymatic modification
AU9358898A (en) Elastic thin-walled articles
AU8824298A (en) Benzothiophenes
AU1442699A (en) Can shaping
AUPP036697A0 (en) Odour-proof package
AU7266998A (en) Packaging
AU9099198A (en) Container
AU1609099A (en) Bottle
AU5593098A (en) Motorcycle
AU7273098A (en) Hyperstructure-forming carriers
AU8338098A (en) Peroxyacids
AU8553198A (en) Container
ZA9811027B (en) S-oxide S,S-dioxide tetrahydrothiopyran phenyloxazolidinones.
AU8637298A (en) Container
AU1494899A (en) Binary adder
AU7208898A (en) Microbicidal benzothiophene s-oxide derivatives